(Q44390471)

2 December 2017

An adaptive first in man dose-escalation study of NGX267: statistical, clinical, and operational considerations (English)

1 reference

2 December 2017

0 references

Anastasia Ivanova

1

1 reference

PubMed ID

19212877

2 December 2017

Michael Murphy

series ordinal

2

1 reference

2 December 2017

1 January 2009

1 reference

Journal of Biopharmaceutical Statistics

2 December 2017

1 reference

2 December 2017

19

1 reference

2 December 2017

2

1 reference

2 December 2017

247-255

1 reference

M1 receptors play a central role in modulating AD-like pathology in transgenic mice

2 December 2017

1 reference

https://api.crossref.org/works/10.1080%2F10543400802609805

Adaptive design in clinical research: issues, opportunities, and recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543400802609805

Therapeutic strategies in Alzheimer's disease: M1 muscarinic agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543400802609805

Adaptive dose finding based on t-statistic for dose-response trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543400802609805

The cholinergic deficiency syndrome and its therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543400802609805

Modified Fibonacci search.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543400802609805

Quantile estimation following non-parametric phase I clinical trials with ordinal response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543400802609805

The continual reassessment method for multiple toxicity grades: a Bayesian quasi-likelihood approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543400802609805

10.1080/10543400802609805

21 January 2018

Identifiers

DOI

1 reference

2 December 2017

1 reference

PubMed ID

19212877